ΔRDW: A Novel Indicator with Predictive Value for the Diagnosis and Treatment of Multiple Diseases

Jingsheng Wang, Qiang Xiao, Yuanmin Li Department of Cardiology, the Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, People’s Republic of ChinaCorrespondence: Yuanmin LiDepartment of Cardiology, the Second Affiliated Hospital, Shandong...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang J, Xiao Q, Li Y
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/f6312f0a55924d22be278c01ed4910ea
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Jingsheng Wang, Qiang Xiao, Yuanmin Li Department of Cardiology, the Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, People’s Republic of ChinaCorrespondence: Yuanmin LiDepartment of Cardiology, the Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, No. 366 Taishan Street, Taian, 271000, People’s Republic of ChinaTel +86-13583843518Fax +86-538-6222036Email Liym575@126.comAbstract: Elevated red blood cell distribution width (RDW) is a powerful predictor of poor prognosis in a variety of diseases, but a single measurement of RDW cannot reflect the dynamic change of diseases. ΔRDW, as a risk stratification tool, can be used to record changes in RDW before and after treatment; also, it allows investigators to name the unit change of RDW in the studied population. So far, there have been few relevant studies on the predictive value of ΔRDW for different diseases; this article aims to review the studies and summaries of the current understandings on the correlation between ΔRDW and disease outcomes.Keywords: red cell distribution width, increment, diagnosis, prognosis